Peer Review History
| Original SubmissionJanuary 16, 2020 |
|---|
|
PONE-D-20-01536 Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India PLOS ONE Dear Dr. Rongsen-Chandola, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 30 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Surbhi Leekha Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include additional information regarding the surveys, questionnaires or interview guides used in the study and ensure that you have provided sufficient details that others could replicate the analyses. If you developed and/or translated surveys, questionnaires or interview guides as part of this study and they are not under a copyright license more restrictive than Creative Commons Attribution (CC-BY), please include a copy, in both the original language and English, as Supporting Information. 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 5. Please ensure that you refer to Figure xxxxx in your text as, if accepted, production will need this reference to link the reader to the figure. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Goyal et al., set out to document their findings on the implementation of the 2015 WHO guidelines on the management of possible serious bacterial infections where referral is not feasible in a select community in Himachal Pradesh, India. The work is highly significant with potential for huge impact in management of sick young infants with sepsis in the developing world. Their strategy is well thought out. However, there are some issues that the team needs to think about: • Was the work based on particular implementation science theoretical framework and if yes can they briefly outline these to enable readers easily understand their contextual approaches from inputs to outcomes. • They have done well to look at health system level barriers such as availability of commodity/supplies and infrastructure, however, there are other health system level issues (so called blocks) such as Service Delivery Systems (Health service organization); Leadership and Governance (health service management); Health Workforce (Human Resources for the provision of Health Services); Health Financing (Resources for service provision); Health Products and Technologies (essential medicines, medical supplies, vaccines, health technologies, and public health commodities required in provision of services); Health Information (Systems for generation, analysis, dissemination, and utilization of health-related information); Health Infrastructure (physical infrastructure, equipment, transport, and Information Communication Technology needed) which would impact on the implementation of the PSBI guidelines. However, these will have best been evaluated through organizational capacity index (assessment). What, is their estimation of how these factors interact in their setting to impact PSBI guidelines implementation activities? • Table 2, section F under clinical deterioration, there is no n value provided whilst there is a percentage value of 3% • Only 20% of ANMs could spontaneously recall PSBI signs and symptoms. Recommendations on training? How can their role in PSBI management be better reinforced? There is need to identify how ANMs and AMOs can further complement other health functionaries in PSBI management. • Is there a checklist on identification of danger signs in SYI that ASHAs utilize while conducting home visits? • The percentage of those who refused referral is quite high at 63%, and warrants a brief discussion of the main causes for this. • Only 30% of families could access referral services yet this was not highlighted as a critical challenge. Solutions should also be proposed on a strengthened referral pathway as a vital pillar in PSBI implementation. • While the study has a well-documented scenario of quality improvement in service delivery around PSBI management, there is need to document the existing health system quality improvement strategy that can be leveraged in future to ensure skills retention so as to avoid challenges such as misclassification of PSBI especially with new staff deployments. • The study raises key issues in availability of ampicillin in PSBI guidelines implementation. This is a critical lesson in implementation of PSBI and the availability of essential medicines such as benzylpenicillin as alternatives. However, a different question of antimicrobial resistance in the case of a restricted drug such as ceftriaxone should be considered. Reviewer #2: The manuscript could benefit from some alignment between the objectives of the project as stated on pages 3 and 4 and the research methods used to achieve these objectives. In particular, the "encourage" objective was not well supported with the interventions used (mainly training and Feedback). There was no mention of how data systems at all levels captured the simplified treatment related data when the treatment was offered and whether data at the ANMs and ASHAS were integrated with the larger health systems for improvement purposes. In examining quality of delivery of the simplified treatment, authors did not indicate whether there was an inter-rater reliability established. Also, there was no description of the simplified treatment intervention and whether fidelity measures for its use were established as these are essential for quality assessment- which the authors indicated that they have completed. Qualitative research instruments were not included, but they were the bases for the recommendations made on how to overcome some of the barriers for offering the simplified treatment. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr Jesse Gitaka Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India PONE-D-20-01536R1 Dear Dr. Rongsen-Chandola, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Surbhi Leekha Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-01536R1 Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India Dear Dr. Rongsen-Chandola: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Surbhi Leekha Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .